Pub Date : 2025-11-19DOI: 10.1016/j.mad.2025.112125
Di Hu, Wen Wen, Hui Li, Zuohui Zhang, Hong Lin, Jia Luo
Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a neurotrophic protein localized in the endoplasmic reticulum (ER) and pivotally involved in maintaining ER homeostasis. The ER is central to protein synthesis, folding, degradation and secretion (proteostasis), and experiences considerable stress in neurodegenerative diseases (NDDs), which activates the unfolded protein response (UPR). Aging, the primary risk factor for NDDS, is associated with impaired ER function. MANF is shown to be protective in various experimental models of NDDs. We hypothesized that the expression of MANF in the brain declines with age, which may increase the vulnerability to NDDs. We measured MANF levels in the brain and plasma of 1-, 4-, 11-, and 22-month-old male and female mice. A progressive decline of MANF levels was observed, with the lowest levels detected in 22 months. Reduced MANF expression was found in aged mice across several brain areas, including the cerebral cortex, olfactory bulb, thalamus, hypothalamus, hippocampus, and cerebellum. There was a sex difference in MANF levels in aged mice. Aging also altered the expression of UPR and MANF interacting proteins. Using cerebellar Purkinje cell (PC)-specific MANF deficient mice, we showed that MANF deficiency impaired motor coordination in female, but not male mice. MANF deficiency weakened spatial learning and memory in both male and female mice. Male MANF deficient mice displayed increased sociability, whereas female mice exhibit social withdrawal. Taken together, MANF expression in the brain declined with age and MANF deficiency impacted neurobehaviors in a sex-specific manner.
{"title":"Age-related alterations in the expression of mesencephalic astrocyte-derived neurotrophic factor in the brain and their impact on neurobehavioral functions","authors":"Di Hu, Wen Wen, Hui Li, Zuohui Zhang, Hong Lin, Jia Luo","doi":"10.1016/j.mad.2025.112125","DOIUrl":"10.1016/j.mad.2025.112125","url":null,"abstract":"<div><div>Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a neurotrophic protein localized in the endoplasmic reticulum (ER) and pivotally involved in maintaining ER homeostasis. The ER is central to protein synthesis, folding, degradation and secretion (proteostasis), and experiences considerable stress in neurodegenerative diseases (NDDs), which activates the unfolded protein response (UPR). Aging, the primary risk factor for NDDS, is associated with impaired ER function. MANF is shown to be protective in various experimental models of NDDs. We hypothesized that the expression of MANF in the brain declines with age, which may increase the vulnerability to NDDs. We measured MANF levels in the brain and plasma of 1-, 4-, 11-, and 22-month-old male and female mice. A progressive decline of MANF levels was observed, with the lowest levels detected in 22 months. Reduced MANF expression was found in aged mice across several brain areas, including the cerebral cortex, olfactory bulb, thalamus, hypothalamus, hippocampus, and cerebellum. There was a sex difference in MANF levels in aged mice. Aging also altered the expression of UPR and MANF interacting proteins. Using cerebellar Purkinje cell (PC)-specific MANF deficient mice, we showed that MANF deficiency impaired motor coordination in female, but not male mice. MANF deficiency weakened spatial learning and memory in both male and female mice. Male MANF deficient mice displayed increased sociability, whereas female mice exhibit social withdrawal. Taken together, MANF expression in the brain declined with age and MANF deficiency impacted neurobehaviors in a sex-specific manner.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112125"},"PeriodicalIF":5.1,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145564292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11DOI: 10.1016/j.mad.2025.112124
Sarah Damanti , Clara Sciorati , Rebecca De Lorenzo , Amanda Avola , Maria Pia Ruggiero , Simona Santoro , Eleonora Senini , Marco Messina , Francesca Farina , Costanza Festorazzi , Giulia Pata , Martina Laffranchi , Martina Mallus , Elena Brioni , Lorena Citterio , Laura Zagato , Marco Simonini , Chiara Lanzani , Paolo Manunta , Angelo A. Manfredi , Patrizia Rovere-Querini
Background
Mitochondria-derived GDF15 and FGF21, known as mitokines, are emerging biomarkers of metabolic stress and aging-related decline. Their roles in energy balance, inflammation, and muscle metabolism suggest potential for predicting geriatric syndromes, yet prospective evidence is limited.
Methods
Plasma GDF15 and FGF21 and multidimensional geriatric assessment at baseline and at 6-year follow-up in 52 community-dwelling adults aged ≥ 65 years from the FRASNET cohort.
Results
Over a six-year follow-up, participants exhibited signs of functional decline, including increased waist circumference, greater fatigue severity, and higher medication use. FGF21 levels declined significantly over time (p = 0.03), whereas GDF15 levels remained stable. Higher baseline GDF15 levels identified individuals at higher risk to become frail (AUC= 0.85 with Fried Phenotype and AUC= 0.96 with Clinical Frailty Scale) or malnourished (AUC=0.94) and at risk to fall (AUC=0.98). FGF21 associated to malnutrition (AUC=0.98). GDF15 prospectively associated to high risk of frailty and negatively associated with physical performance and nutritional status after six years.
Conclusions
In this cohort, higher baseline levels of GDF15 and FGF21 were associated with the risk to become frail or malnourished. These findings support the integration of mitokines into early risk stratification tools for older adults. Further validation in larger cohorts is warranted.
{"title":"Circulating mitokines GDF-15 and FGF21 are associated with frailty, sarcopenia, and malnutrition in older adults: Evidence from the FRASNET study","authors":"Sarah Damanti , Clara Sciorati , Rebecca De Lorenzo , Amanda Avola , Maria Pia Ruggiero , Simona Santoro , Eleonora Senini , Marco Messina , Francesca Farina , Costanza Festorazzi , Giulia Pata , Martina Laffranchi , Martina Mallus , Elena Brioni , Lorena Citterio , Laura Zagato , Marco Simonini , Chiara Lanzani , Paolo Manunta , Angelo A. Manfredi , Patrizia Rovere-Querini","doi":"10.1016/j.mad.2025.112124","DOIUrl":"10.1016/j.mad.2025.112124","url":null,"abstract":"<div><h3>Background</h3><div>Mitochondria-derived GDF15 and FGF21, known as mitokines, are emerging biomarkers of metabolic stress and aging-related decline. Their roles in energy balance, inflammation, and muscle metabolism suggest potential for predicting geriatric syndromes, yet prospective evidence is limited.</div></div><div><h3>Methods</h3><div>Plasma GDF15 and FGF21 and multidimensional geriatric assessment at baseline and at 6-year follow-up in 52 community-dwelling adults aged ≥ 65 years from the FRASNET cohort.</div></div><div><h3>Results</h3><div>Over a six-year follow-up, participants exhibited signs of functional decline, including increased waist circumference, greater fatigue severity, and higher medication use. FGF21 levels declined significantly over time (p = 0.03), whereas GDF15 levels remained stable. Higher baseline GDF15 levels identified individuals at higher risk to become frail (AUC= 0.85 with Fried Phenotype and AUC= 0.96 with Clinical Frailty Scale) or malnourished (AUC=0.94) and at risk to fall (AUC=0.98). FGF21 associated to malnutrition (AUC=0.98). GDF15 prospectively associated to high risk of frailty and negatively associated with physical performance and nutritional status after six years.</div></div><div><h3>Conclusions</h3><div>In this cohort, higher baseline levels of GDF15 and FGF21 were associated with the risk to become frail or malnourished. These findings support the integration of mitokines into early risk stratification tools for older adults. Further validation in larger cohorts is warranted.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112124"},"PeriodicalIF":5.1,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145513256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-08DOI: 10.1016/j.mad.2025.112123
Fatemeh Tabassi Mofrad, Chris Patrick Pflanz, John Gallacher
Ageing is commonly associated with neuroanatomical changes in brain structure, underscoring the importance of distinguishing normal age-related alterations from those linked to pathological neurodegeneration. Despite this critical need, a standardized benchmark for identifying brain volumetric signatures of ageing remains lacking, and the influence of biological sex on age-related changes in brain volume is not yet fully understood. To address the above-mentioned gaps, we employed T1-weighted MRI images of 46,111 cognitively healthy individuals aged 44–83 from the UK Biobank cohort, and generated comprehensive maps of all the linear and non-linear trajectories of alterations in the grey matter volumes (GMVs) of subcortical regions across males and females. According to our findings, Brainstem, bilateral Amygdala and Hippocampus are the most susceptible subcortical regions to age-related atrophy, with males being generally more prone to such alterations. However, ageing proves to have a dual function as we also observed age-related inflammation in GMVs of Pallidum and Caudate which accelerates during older age and remains consistent across males and females. Our findings guide regenerative strategies and therapeutic interventions by locating subcortical regions most vulnerable to age-related atrophy and inflammation and establish a benchmark for sex-specific typical patterns of subcortical grey matter alterations due to ageing.
{"title":"An atlas of age- and sex-related volumetric alterations of grey matter in subcortical regions: The case of 46,111 UK Biobank participants","authors":"Fatemeh Tabassi Mofrad, Chris Patrick Pflanz, John Gallacher","doi":"10.1016/j.mad.2025.112123","DOIUrl":"10.1016/j.mad.2025.112123","url":null,"abstract":"<div><div>Ageing is commonly associated with neuroanatomical changes in brain structure, underscoring the importance of distinguishing normal age-related alterations from those linked to pathological neurodegeneration. Despite this critical need, a standardized benchmark for identifying brain volumetric signatures of ageing remains lacking, and the influence of biological sex on age-related changes in brain volume is not yet fully understood. To address the above-mentioned gaps, we employed T1-weighted MRI images of 46,111 cognitively healthy individuals aged 44–83 from the UK Biobank cohort, and generated comprehensive maps of all the linear and non-linear trajectories of alterations in the grey matter volumes (GMVs) of subcortical regions across males and females. According to our findings, Brainstem, bilateral Amygdala and Hippocampus are the most susceptible subcortical regions to age-related atrophy, with males being generally more prone to such alterations. However, ageing proves to have a dual function as we also observed age-related inflammation in GMVs of Pallidum and Caudate which accelerates during older age and remains consistent across males and females. Our findings guide regenerative strategies and therapeutic interventions by locating subcortical regions most vulnerable to age-related atrophy and inflammation and establish a benchmark for sex-specific typical patterns of subcortical grey matter alterations due to ageing.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112123"},"PeriodicalIF":5.1,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145489163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-04DOI: 10.1016/j.mad.2025.112122
Sobia Zaidi , Suman Asalla , Raziyeh Abdolahipour , Agnes O. Portuphy , Marziyeh S. Jahromi , Harrison T. Muturi , Getachew D. Belew , Ramiro Malgor , Sivarajan Kumarasamy , Sonia M. Najjar
Background
Hepatic fibrosis increases with aging, but its physiological progression and underlying mechanisms remain poorly defined. Given that CEACAM1 repression causes metabolic dysfunction and liver injury, the current studies investigated whether it mediates age-related hepatic fibrosis.
Materials and methods
The metabolic phenotype, histological, immunochemical and Western blot analyses were performed in male C57BL6/J wild-type and LCC1 mice with liver-specific CEACAM1 overexpression at 2–17 months of age.
Results
Progression of metabolic dysfunction during physiological aging began with increased lipolysis-derived fatty acids, followed by hepatic insulin resistance with compensatory increase in insulin secretion and a decline in hepatic insulin clearance mediated initially by compromised CEACAM1 phosphorylation and then expression. Resultant hyperinsulinemia drove hepatic steatosis, followed by Th1 inflammatory response and subsequently, hepatic fibrosis at 17 months of age. These histological abnormalities regressed in LCC1 mice with protected hepatic CEACAM1 levels. Accordingly, LCC1 mice exhibited survival advantage.
Discussion
This age-related mapping demonstrated that early metabolic alterations impaired insulin clearance with a progressive loss of CEACAM1. Resultant hyperinsulinemia drove hepatic steatosis followed by inflammation and ultimately, hepatic fibrosis in wild-type but not LCC1 mice. Together with survival benefit of LCC1, these observations propose that protecting hepatic CEACAM1 prevents age-related hepatic fibrosis and bestows longevity.
{"title":"Diminished CEACAM1 level plays a critical role in age-related hepatic fibrosis","authors":"Sobia Zaidi , Suman Asalla , Raziyeh Abdolahipour , Agnes O. Portuphy , Marziyeh S. Jahromi , Harrison T. Muturi , Getachew D. Belew , Ramiro Malgor , Sivarajan Kumarasamy , Sonia M. Najjar","doi":"10.1016/j.mad.2025.112122","DOIUrl":"10.1016/j.mad.2025.112122","url":null,"abstract":"<div><h3>Background</h3><div>Hepatic fibrosis increases with aging, but its physiological progression and underlying mechanisms remain poorly defined. Given that CEACAM1 repression causes metabolic dysfunction and liver injury, the current studies investigated whether it mediates age-related hepatic fibrosis.</div></div><div><h3>Materials and methods</h3><div>The metabolic phenotype, histological, immunochemical and Western blot analyses were performed in male C57BL6/J wild-type and LCC1 mice with liver-specific CEACAM1 overexpression at 2–17 months of age.</div></div><div><h3>Results</h3><div>Progression of metabolic dysfunction during physiological aging began with increased lipolysis-derived fatty acids, followed by hepatic insulin resistance with compensatory increase in insulin secretion and a decline in hepatic insulin clearance mediated initially by compromised CEACAM1 phosphorylation and then expression. Resultant hyperinsulinemia drove hepatic steatosis, followed by Th1 inflammatory response and subsequently, hepatic fibrosis at 17 months of age. These histological abnormalities regressed in LCC1 mice with protected hepatic CEACAM1 levels. Accordingly, LCC1 mice exhibited survival advantage.</div></div><div><h3>Discussion</h3><div>This age-related mapping demonstrated that early metabolic alterations impaired insulin clearance with a progressive loss of CEACAM1. Resultant hyperinsulinemia drove hepatic steatosis followed by inflammation and ultimately, hepatic fibrosis in wild-type but not LCC1 mice. Together with survival benefit of LCC1, these observations propose that protecting hepatic CEACAM1 prevents age-related hepatic fibrosis and bestows longevity.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112122"},"PeriodicalIF":5.1,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-17DOI: 10.1016/j.mad.2025.112120
Yong-Ha Jo , Hyun-Ok Song , Dong-Sung Lee , Jeong Hoon Cho
Morin, a dietary flavonoid with antioxidant and metabolic activity, promotes healthy ageing in Caenorhabditis elegans. Morin extended lifespan by ∼18 % and alleviated age-related decline in neuronal integrity, locomotion, learning and memory, and intestinal fat accumulation. Mitochondrial potential was moderately decreased, suggesting mild uncoupler–like activity. Morin downregulated daf-2 and upregulated daf-16, accompanied by enhanced DAF-16::GFP nuclear localization, indicative of IIS/FOXO pathway activation. Gene expression profiling revealed modulation of mitochondrial stress–responsive (atfs-1, fmo-2), antioxidant (gst-4, hsf-1), and lipid metabolism (fat-6, fat-7) genes. Notably, pink-1 and pdr-1 expression increased, whereas morin’s neuroprotective effects were abolished in pink-1; pdr-1 mutants, suggesting that its benefits may involve PINK-1/PDR-1–dependent mitophagy or mitochondrial quality control. Collectively, morin enhances stress resilience and mitochondrial homeostasis through IIS/FOXO-associated regulation, supporting its potential as a natural compound that promotes healthspan.
{"title":"Morin enhances healthspan and neuroprotection in Caenorhabditis elegans via mitochondrial stress adaptation","authors":"Yong-Ha Jo , Hyun-Ok Song , Dong-Sung Lee , Jeong Hoon Cho","doi":"10.1016/j.mad.2025.112120","DOIUrl":"10.1016/j.mad.2025.112120","url":null,"abstract":"<div><div>Morin, a dietary flavonoid with antioxidant and metabolic activity, promotes healthy ageing in <em>Caenorhabditis elegans</em>. Morin extended lifespan by ∼18 % and alleviated age-related decline in neuronal integrity, locomotion, learning and memory, and intestinal fat accumulation. Mitochondrial potential was moderately decreased, suggesting mild uncoupler–like activity. Morin downregulated <em>daf-2</em> and upregulated <em>daf-16</em>, accompanied by enhanced DAF-16::GFP nuclear localization, indicative of IIS/FOXO pathway activation. Gene expression profiling revealed modulation of mitochondrial stress–responsive (<em>atfs-1</em>, <em>fmo-2</em>), antioxidant (<em>gst-4</em>, <em>hsf-1</em>), and lipid metabolism (<em>fat-6</em>, <em>fat-7</em>) genes. Notably, <em>pink-1</em> and <em>pdr-1</em> expression increased, whereas morin’s neuroprotective effects were abolished in <em>pink-1; pdr-1</em> mutants, suggesting that its benefits may involve PINK-1/PDR-1–dependent mitophagy or mitochondrial quality control. Collectively, morin enhances stress resilience and mitochondrial homeostasis through IIS/FOXO-associated regulation, supporting its potential as a natural compound that promotes healthspan.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112120"},"PeriodicalIF":5.1,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145313211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-15DOI: 10.1016/j.mad.2025.112119
Fatma Hastaoǧlu , Sonia de Pascual-Teresa
This study explores the scientific landscape linking the Mediterranean Diet Adherence Screener (MEDAS) to aging-related health outcomes through a comprehensive bibliometric and scoping review approach. Given the increasing prevalence of chronic conditions in aging populations, diet has emerged as a modifiable factor with potential to enhance health span. The Mediterranean diet, characterized by high intake of vegetables, fruits, olive oil, and legumes, has shown promise in promoting cardiovascular, neurological, and metabolic health. MEDAS, a validated 14-item questionnaire developed within the PREDIMED study, serves as a practical tool to assess adherence to this dietary pattern. The current analysis spans literature from 2000 to 2025 and includes 203 peer-reviewed publications indexed in Web of Science. Using VOSviewer and CiteSpace software, co-occurrence maps, keyword clusters, and disease associations were visualized. Results indicate that fish, vegetables, nuts, and olive oil are the most frequently studied MEDAS components. Cardiovascular aging emerged as the most researched domain, followed by general aging and neurodegenerative conditions, while dermatological aging remains underexplored. Key themes such as cognitive decline, frailty, inflammaging, and longevity underscore the multidimensional role of MEDAS. Findings suggest that MEDAS is not only a dietary adherence measure but also a valuable instrument in preventive geriatric nutrition. Its global adaptability, simplicity, and strong predictive value make it a suitable tool for clinical and community-based nutritional strategies. This study contributes a consolidated foundation for future interdisciplinary efforts to integrate diet-based approaches into aging research and public health policy.
本研究通过全面的文献计量学和范围审查方法,探讨了地中海饮食依从筛选(MEDAS)与衰老相关健康结果之间的科学联系。鉴于慢性疾病在老年人群中的患病率日益增加,饮食已成为一个可改变的因素,具有提高健康寿命的潜力。地中海饮食的特点是大量摄入蔬菜、水果、橄榄油和豆类,在促进心血管、神经和代谢健康方面表现出了希望。MEDAS是PREDIMED研究中开发的一份经过验证的14项问卷,可作为评估这种饮食模式依从性的实用工具。目前的分析涵盖了2000年至2025年的文献,包括203篇被Web of Science收录的同行评议出版物。使用VOSviewer和CiteSpace软件,对共现图、关键词集群和疾病关联进行可视化。结果表明,鱼类、蔬菜、坚果和橄榄油是最常被研究的MEDAS成分。心血管老化是研究最多的领域,其次是一般老化和神经退行性疾病,而皮肤老化仍未得到充分研究。认知能力下降、虚弱、炎症和长寿等关键主题强调了MEDAS的多维作用。研究结果表明,MEDAS不仅是一种饮食依从性指标,而且是预防老年营养的一种有价值的工具。它的全球适应性、简单性和强大的预测价值使其成为临床和社区营养策略的合适工具。这项研究为未来跨学科的努力奠定了坚实的基础,将基于饮食的方法整合到老龄化研究和公共卫生政策中。
{"title":"Linking nutrition and aging: A cross-domain analysis of Mediterranean Diet Adhesion Screener components","authors":"Fatma Hastaoǧlu , Sonia de Pascual-Teresa","doi":"10.1016/j.mad.2025.112119","DOIUrl":"10.1016/j.mad.2025.112119","url":null,"abstract":"<div><div>This study explores the scientific landscape linking the Mediterranean Diet Adherence Screener (MEDAS) to aging-related health outcomes through a comprehensive bibliometric and scoping review approach. Given the increasing prevalence of chronic conditions in aging populations, diet has emerged as a modifiable factor with potential to enhance health span. The Mediterranean diet, characterized by high intake of vegetables, fruits, olive oil, and legumes, has shown promise in promoting cardiovascular, neurological, and metabolic health. MEDAS, a validated 14-item questionnaire developed within the PREDIMED study, serves as a practical tool to assess adherence to this dietary pattern. The current analysis spans literature from 2000 to 2025 and includes 203 peer-reviewed publications indexed in Web of Science. Using VOSviewer and CiteSpace software, co-occurrence maps, keyword clusters, and disease associations were visualized. Results indicate that fish, vegetables, nuts, and olive oil are the most frequently studied MEDAS components. Cardiovascular aging emerged as the most researched domain, followed by general aging and neurodegenerative conditions, while dermatological aging remains underexplored. Key themes such as cognitive decline, frailty, inflammaging, and longevity underscore the multidimensional role of MEDAS. Findings suggest that MEDAS is not only a dietary adherence measure but also a valuable instrument in preventive geriatric nutrition. Its global adaptability, simplicity, and strong predictive value make it a suitable tool for clinical and community-based nutritional strategies. This study contributes a consolidated foundation for future interdisciplinary efforts to integrate diet-based approaches into aging research and public health policy.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112119"},"PeriodicalIF":5.1,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145313205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-09DOI: 10.1016/j.mad.2025.112118
Minghui Li , Tianzi Li , Xufei Zhang , Kun Li , Ziqiang Wang
Aging is a natural biological process characterized by progressive cellular and functional decline, significantly increasing susceptibility to age-related diseases. Long non-coding RNAs (lncRNAs) are increasingly recognized as critical regulators of cellular processes implicated in aging and age-related diseases. Among these, lncRNA erythrocyte membrane protein band 4.1 like 4 A antisense RNA 1 (EPB41L4A-AS1) has emerged as a key player with significant dysregulation across diverse age-related diseases including cancer, Alzheimer's disease (AD), and type 2 diabetes mellitus (T2DM). This review synthesizes current evidence showing that EPB41L4A-AS1 functions primarily as a tumor suppressor in many cancers, regulates neuronal autophagy and energy metabolism in AD, and modulates inflammatory and metabolic pathways in T2DM. Mechanistically, EPB41L4A-AS1 exerts its effects—via miRNA sponging, regulating key signaling pathways (NF-κB, Rho/ROCK), influencing histone modifications, and modulating cellular metabolism (glycolysis, glutaminolysis, NAD+/ATP synthesis). The compelling evidence positions EPB41L4A-AS1 as a promising, multi-faceted therapeutic target for mitigating the burden of age-related diseases.
{"title":"lncRNA EPB41L4A-AS1: A promising therapeutic target for aging and age-related diseases","authors":"Minghui Li , Tianzi Li , Xufei Zhang , Kun Li , Ziqiang Wang","doi":"10.1016/j.mad.2025.112118","DOIUrl":"10.1016/j.mad.2025.112118","url":null,"abstract":"<div><div>Aging is a natural biological process characterized by progressive cellular and functional decline, significantly increasing susceptibility to age-related diseases. Long non-coding RNAs (lncRNAs) are increasingly recognized as critical regulators of cellular processes implicated in aging and age-related diseases. Among these, lncRNA erythrocyte membrane protein band 4.1 like 4 A antisense RNA 1 (EPB41L4A-AS1) has emerged as a key player with significant dysregulation across diverse age-related diseases including cancer, Alzheimer's disease (AD), and type 2 diabetes mellitus (T2DM). This review synthesizes current evidence showing that EPB41L4A-AS1 functions primarily as a tumor suppressor in many cancers, regulates neuronal autophagy and energy metabolism in AD, and modulates inflammatory and metabolic pathways in T2DM. Mechanistically, EPB41L4A-AS1 exerts its effects—via miRNA sponging, regulating key signaling pathways (NF-κB, Rho/ROCK), influencing histone modifications, and modulating cellular metabolism (glycolysis, glutaminolysis, NAD+/ATP synthesis). The compelling evidence positions EPB41L4A-AS1 as a promising, multi-faceted therapeutic target for mitigating the burden of age-related diseases.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112118"},"PeriodicalIF":5.1,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145258577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-26DOI: 10.1016/j.mad.2025.112117
Mario Virgilio Papa , Chiara Ceolin , Francesco Boschele , Raffaele Pagliuca , Giuseppe Sergi , Marina De Rui
Background
Given the increasing interest for Growth Differentiation Factor-15 (GDF-15) in muscle decline, this study aims to evaluate the association between circulating levels of GDF-15 and muscle mass and sarcopenia through a systematic review and meta-analysis.
Methods
The research, in accordance with PRISMA and MOOSE guidelines, involved PubMed, Embase, and Cochrane Libraries. Two meta-analyses were performed: (1) comparison of GDF-15 levels in sarcopenic vs non-sarcopenic individuals; (2) correlation between GDF-15 and muscle mass.
Results
A total of 7 studies met the inclusion criteria (total n = 2344) enrolling both adults aged ≥ 60 years (6/7 studies) and a younger cohort (42 years [IQR 31.8–51]). The first meta-analysis, based on 4 studies (n = 1393), showed significantly higher levels of GDF-15 in sarcopenic individuals (r = 0.482). The second meta-analysis, involving 4 studies (n = 1400), found a significant inverse correlation between GDF-15 and muscle mass (r = -0.221).
Conclusions
Sarcopenic individuals had higher circulating GDF-15. Together with the inverse correlation between GDF-15 and muscle mass observed, these findings show a small-to-moderate association between elevated GDF-15 and sarcopenic phenotypes in older adults. However, the limited number of studies and high heterogeneity for the sarcopenia comparison warrant cautious interpretation and underscore the need for larger, longitudinal investigations.
{"title":"The stress-responsive cytokine GDF-15 and sarcopenia: A systematic review and meta-analysis on aging muscle decline","authors":"Mario Virgilio Papa , Chiara Ceolin , Francesco Boschele , Raffaele Pagliuca , Giuseppe Sergi , Marina De Rui","doi":"10.1016/j.mad.2025.112117","DOIUrl":"10.1016/j.mad.2025.112117","url":null,"abstract":"<div><h3>Background</h3><div>Given the increasing interest for Growth Differentiation Factor-15 (GDF-15) in muscle decline, this study aims to evaluate the association between circulating levels of GDF-15 and muscle mass and sarcopenia through a systematic review and meta-analysis.</div></div><div><h3>Methods</h3><div>The research, in accordance with PRISMA and MOOSE guidelines, involved PubMed, Embase, and Cochrane Libraries. Two meta-analyses were performed: (1) comparison of GDF-15 levels in sarcopenic vs non-sarcopenic individuals; (2) correlation between GDF-15 and muscle mass.</div></div><div><h3>Results</h3><div>A total of 7 studies met the inclusion criteria (total n = 2344) enrolling both adults aged ≥ 60 years (6/7 studies) and a younger cohort (42 years [IQR 31.8–51]). The first meta-analysis, based on 4 studies (n = 1393), showed significantly higher levels of GDF-15 in sarcopenic individuals (r = 0.482). The second meta-analysis, involving 4 studies (n = 1400), found a significant inverse correlation between GDF-15 and muscle mass (r = -0.221).</div></div><div><h3>Conclusions</h3><div>Sarcopenic individuals had higher circulating GDF-15. Together with the inverse correlation between GDF-15 and muscle mass observed, these findings show a small-to-moderate association between elevated GDF-15 and sarcopenic phenotypes in older adults. However, the limited number of studies and high heterogeneity for the sarcopenia comparison warrant cautious interpretation and underscore the need for larger, longitudinal investigations.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112117"},"PeriodicalIF":5.1,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-24DOI: 10.1016/j.mad.2025.112114
Jeff Didier , Sébastien De Landtsheer , Maria Pires Pacheco , Ali Kishk , Jochen G. Schneider , David Goldeck , Graham Pawelec , Dominik Spira , Ilja Demuth , Thomas Sauter
Frailty is a geriatric condition with multidimensional consequences that strongly affect older adults’ quality of life. The lack of a universal standard to describe, diagnose, and treat frailty further complicates this situation. Nowadays, multitudinous frailty assessment tools are applied depending on the regional and clinical context, adding complexity by increasing heterogeneity in the definition and characterization of frailty. Better insights into the causes and pathophysiology of frailty and its early stages are required to establish strong and accurately tailored treatment rationales for frail patients. We analysed participants aged 60 and above using cross-sectional biochemical and survey data from the Berlin Aging Study II (BASE-II, N = 1512, pre-frail=470, frail=14), applying machine-learning techniques to investigate determinants of physical frailty measured by Fried et al.’s 5-item frailty phenotype. Our findings highlight new prognostic sex-specific biomarkers of pre-frailty (the early stage of frailty) with possible clinical applications, enriching the current sex-agnostic diagnostic scores with easy monitorable physical and physiological characteristics. Low appendicular lean mass and high fat composition in men, or vitamin D deficiency and high white blood cell counts in women, emerged as strong indicators of the respective pre-frailty profiles. Because the number of fully frail individuals was extremely small (n = 14, <1 %), our findings should be interpreted as reflecting predictors of pre-frailty, not of frailty itself. We conclude that understanding the development of frailty remains a complex challenge, and that sex-specific differences must be considered by clinical geriatricians and researchers.
虚弱是一种老年疾病,具有多方面的后果,严重影响老年人的生活质量。缺乏描述、诊断和治疗虚弱的通用标准使这种情况进一步复杂化。如今,根据地区和临床情况,应用了多种虚弱评估工具,这增加了虚弱定义和特征的异质性,从而增加了复杂性。需要更好地了解虚弱的原因和病理生理学及其早期阶段,以便为虚弱患者建立强有力和准确定制的治疗依据。我们使用来自柏林老龄化研究II (BASE-II, N = 1512,pre-虚弱=470,虚弱=14)的横断面生化和调查数据分析了60岁及以上的参与者,并应用机器学习技术来研究Fried等人的5项虚弱表型测量的身体虚弱的决定因素。我们的研究结果强调了具有潜在临床应用价值的新的预脆弱(脆弱的早期阶段)预后性别特异性生物标志物,丰富了目前的性别不可知的诊断评分,具有易于监测的生理和生理特征。男性阑尾瘦质量低、脂肪含量高,女性缺乏维生素D、白细胞数量高,这些都是各自脆弱前特征的有力指标。由于完全虚弱个体的数量非常少(n = 14,<1 %),我们的发现应该被解释为反映了虚弱前期的预测因子,而不是虚弱本身。我们的结论是,了解衰弱的发展仍然是一个复杂的挑战,临床老年病学家和研究人员必须考虑到性别特异性差异。
{"title":"Clinical data-driven classification of pre-frailty reveals sex-specific patterns – Data from the Berlin Aging Study II (BASE-II)","authors":"Jeff Didier , Sébastien De Landtsheer , Maria Pires Pacheco , Ali Kishk , Jochen G. Schneider , David Goldeck , Graham Pawelec , Dominik Spira , Ilja Demuth , Thomas Sauter","doi":"10.1016/j.mad.2025.112114","DOIUrl":"10.1016/j.mad.2025.112114","url":null,"abstract":"<div><div>Frailty is a geriatric condition with multidimensional consequences that strongly affect older adults’ quality of life. The lack of a universal standard to describe, diagnose, and treat frailty further complicates this situation. Nowadays, multitudinous frailty assessment tools are applied depending on the regional and clinical context, adding complexity by increasing heterogeneity in the definition and characterization of frailty. Better insights into the causes and pathophysiology of frailty and its early stages are required to establish strong and accurately tailored treatment rationales for frail patients. We analysed participants aged 60 and above using cross-sectional biochemical and survey data from the Berlin Aging Study II (BASE-II, N = 1512, pre-frail=470, frail=14), applying machine-learning techniques to investigate determinants of physical frailty measured by Fried et al.’s 5-item frailty phenotype. Our findings highlight new prognostic sex-specific biomarkers of pre-frailty (the early stage of frailty) with possible clinical applications, enriching the current sex-agnostic diagnostic scores with easy monitorable physical and physiological characteristics. Low appendicular lean mass and high fat composition in men, or vitamin D deficiency and high white blood cell counts in women, emerged as strong indicators of the respective pre-frailty profiles. Because the number of fully frail individuals was extremely small (n = 14, <1 %), our findings should be interpreted as reflecting predictors of pre-frailty, not of frailty itself. We conclude that understanding the development of frailty remains a complex challenge, and that sex-specific differences must be considered by clinical geriatricians and researchers.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112114"},"PeriodicalIF":5.1,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145154937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by cognitive decline, amyloid-β (Aβ) plaques, and neurofibrillary tangles. Aβ1–42 oligomers exert neurotoxic and pro-inflammatory effects. Astrocytes maintain brain homeostasis, and their dysfunction contributes to AD progression. This study investigates the impact of Aβ1–42 oligomers on primary human astrocytes from healthy individuals and AD patients. Our findings show that astrocytes from both groups internalise Aβ1–42 oligomers. In healthy astrocytes, internalisation enhances proteasome activity, whereas in AD astrocytes, it reduces it. Aβ1–42 oligomers induce calcium dyshomeostasis and mitochondrial membrane potential alterations in both groups. Interestingly, oligomers induce apoptosis in a subset of healthy astrocytes, while surviving ones become reactive and hyperproliferative, releasing neuroinflammatory and neurotrophic molecules. Conversely, Aβ1–42 drives AD astrocytes into senescence, characterised by increased β-galactosidase activity, p14ARF expression, senescence-associated secretory phenotype (SASP), and heterochromatin foci. Importantly, conditioned media from Aβ1–42-treated AD astrocytes, but not from healthy ones, cause death of differentiated SH-SY5Y neuron-like cells, suggesting that senescent astrocytes contribute to neurotoxicity. These findings reveal differential astrocytic responses to Aβ1–42 oligomers, emphasising the importance of astrocyte senescence in AD pathogenesis. This research offers insight into cellular mechanisms underlying AD and may support the development of innovative therapeutic strategies for neurodegenerative diseases.
{"title":"Human astrocytes from healthy individuals and Alzheimer’s patients respond differently to Aβ1–42 oligomers, triggering distinct paths of reactivity and senescence","authors":"Sara Ristori , Gianmarco Bertoni , Alessandra Bigi , Cristina Cecchi , Manuela Sollazzo , Luisa Iommarini , Daniela Monti , Elisa Bientinesi","doi":"10.1016/j.mad.2025.112116","DOIUrl":"10.1016/j.mad.2025.112116","url":null,"abstract":"<div><div>Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by cognitive decline, amyloid-β (Aβ) plaques, and neurofibrillary tangles. Aβ<sub>1–42</sub> oligomers exert neurotoxic and pro-inflammatory effects. Astrocytes maintain brain homeostasis, and their dysfunction contributes to AD progression. This study investigates the impact of Aβ<sub>1–42</sub> oligomers on primary human astrocytes from healthy individuals and AD patients. Our findings show that astrocytes from both groups internalise Aβ<sub>1–42</sub> oligomers. In healthy astrocytes, internalisation enhances proteasome activity, whereas in AD astrocytes, it reduces it. Aβ<sub>1–42</sub> oligomers induce calcium dyshomeostasis and mitochondrial membrane potential alterations in both groups. Interestingly, oligomers induce apoptosis in a subset of healthy astrocytes, while surviving ones become reactive and hyperproliferative, releasing neuroinflammatory and neurotrophic molecules. Conversely, Aβ<sub>1–42</sub> drives AD astrocytes into senescence, characterised by increased β-galactosidase activity, p14<sup>ARF</sup> expression, senescence-associated secretory phenotype (SASP), and heterochromatin foci. Importantly, conditioned media from Aβ<sub>1–42</sub>-treated AD astrocytes, but not from healthy ones, cause death of differentiated SH-SY5Y neuron-like cells, suggesting that senescent astrocytes contribute to neurotoxicity. These findings reveal differential astrocytic responses to Aβ<sub>1–42</sub> oligomers, emphasising the importance of astrocyte senescence in AD pathogenesis. This research offers insight into cellular mechanisms underlying AD and may support the development of innovative therapeutic strategies for neurodegenerative diseases.</div></div>","PeriodicalId":18340,"journal":{"name":"Mechanisms of Ageing and Development","volume":"228 ","pages":"Article 112116"},"PeriodicalIF":5.1,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145176423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}